APOB and myocardial infarction: A prospective study of 25,480 patients from the Copenhagen General Population Study during a median 11 years of follow up found that VLDL cholesterol explained 50% of the myocardial infarction risk from elevated apoB-containing lipoproteins, whereas VLDL triglycerides did not explain risk (15).